X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CIRUGIA ESPANOLA

期刊標題檢索 CIR ESPAN 最新評論: Whether the subject of the manuscript is suitable for the scope specif... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CIRUGIA ESPANOLA]您好,您是該頁面的第 8763 位訪客。

期刊簡介
期刊名稱CIRUGIA ESPANOLA CIRUGIA ESPANOLA
LetPub Score
4.9
50 ratings
Rate

Reputation
6.2

Influence
3.5

Speed
7.0

期刊簡稱CIR ESPAN
ISSN0009-739X
E-ISSN1578-147X
h-index21
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.200.2190.491
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Surgery
Q3325 / 551

自引率 (2023-2024)15.40%自引率趨勢
掲載範囲
Cirugía Española, an official body of the Asociación Española de Cirujanos (Spanish Association of Surgeons), will consider original articles, reviews, editorials, special articles, scientific letters, letters to the editor, and medical images for publication; all of these will be submitted to an anonymous external peer review process. There is also the possibility of accepting book reviews of recent publications related to General and Digestive Surgery.
官方網站Cirugía Espa ola
在線稿件提交https://www.editorialmanager.com/CIRESP
開放訪問No
出版商Ediciones Doyma, S.L.
主題領域SURGERY
出版國/地區SPAIN
發行頻率月刊
創刊年1970
每年文章數86每年文章數趨勢
黃金OA百分比0.87%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
SURGERYSCIEQ3177/290
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-739X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CIRUGIA ESPANOLA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640816
    BIOMATERIALS570028
    BIOMEDICINE & PHARMACOTHERAPY498338
    Frontiers in Pharmacology486746
    JOURNAL OF ETHNOPHARMACOLOGY477538
    Journal of Materials Chemistry B476057
    Frontiers in Immunology457917
    COLLOIDS AND SURFACES B-BIOINTERFACES419218
    COMPUTERS IN BIOLOGY AND MEDICINE416354
    Frontiers in Oncology413430
  •  

    CIRUGIA ESPANOLA CIRUGIA ESPANOLA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CIRUGIA ESPANOLA] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:08:28 評論於
Whether the subject of the manuscript is suitable for the scope specified by the journal; the audience of the journal; the review and publication cycle of the journal
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:52:52 評論於
Journals in the research field that are more widely recognized for the quality of their submissions or are developing towards improvement; If there are considerations such as time constraints, acceptance rates, and review speeds can be taken into account
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 12:40:47 評論於
Two equally good journals, how to choose which one to submit to?
(0) 讚! | 深渊兴业

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 19:46:40 評論於
Are there any principles for selecting publications?
(0) 讚! | 龙鳞孝礼

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CIRUGIA ESPANOLA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*